Vertex Pharmaceuticals Statistics
Total Valuation
VRTX has a market cap or net worth of $138.69 billion. The enterprise value is $135.35 billion.
| Market Cap | 138.69B |
| Enterprise Value | 135.35B |
Important Dates
The last earnings date was Monday, November 2, 2026, after market close.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VRTX has 253.54 million shares outstanding. The number of shares has decreased by -1.01% in one year.
| Current Share Class | 253.54M |
| Shares Outstanding | 253.54M |
| Shares Change (YoY) | -1.01% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.20% |
| Owned by Institutions (%) | 97.02% |
| Float | 252.77M |
Valuation Ratios
The trailing PE ratio is 35.18 and the forward PE ratio is 28.99. VRTX's PEG ratio is 2.37.
| PE Ratio | 35.18 |
| Forward PE | 28.99 |
| PS Ratio | 10.71 |
| Forward PS | 9.67 |
| PB Ratio | 6.63 |
| P/TBV Ratio | 13.92 |
| P/FCF Ratio | 43.31 |
| P/OCF Ratio | 37.54 |
| PEG Ratio | 2.37 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.54, with an EV/FCF ratio of 42.27.
| EV / Earnings | 34.04 |
| EV / Sales | 10.45 |
| EV / EBITDA | 26.54 |
| EV / EBIT | 27.65 |
| EV / FCF | 42.27 |
Financial Position
The company has a current ratio of 2.34, with a Debt / Equity ratio of 0.31.
| Current Ratio | 2.34 |
| Quick Ratio | 1.72 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | 1.20 |
| Debt / FCF | 2.02 |
| Interest Coverage | 107.34 |
Financial Efficiency
Return on equity (ROE) is 20.80% and return on invested capital (ROIC) is 23.07%.
| Return on Equity (ROE) | 20.80% |
| Return on Assets (ROA) | 10.62% |
| Return on Invested Capital (ROIC) | 23.07% |
| Return on Capital Employed (ROCE) | 17.65% |
| Weighted Average Cost of Capital (WACC) | 5.56% |
| Revenue Per Employee | $2.02M |
| Profits Per Employee | $621,234 |
| Employee Count | 6,400 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 3.02 |
Taxes
In the past 12 months, VRTX has paid $783.20 million in taxes.
| Income Tax | 783.20M |
| Effective Tax Rate | 16.46% |
Stock Price Statistics
The stock price has increased by +29.87% in the last 52 weeks. The beta is 0.28, so VRTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +29.87% |
| 50-Day Moving Average | 523.04 |
| 200-Day Moving Average | 482.70 |
| Relative Strength Index (RSI) | 57.33 |
| Average Volume (20 Days) | 1,644,769 |
Short Selling Information
The latest short interest is 4.26 million, so 1.68% of the outstanding shares have been sold short.
| Short Interest | 4.26M |
| Short Previous Month | 4.50M |
| Short % of Shares Out | 1.68% |
| Short % of Float | 1.69% |
| Short Ratio (days to cover) | 3.66 |
Income Statement
In the last 12 months, VRTX had revenue of $12.95 billion and earned $3.98 billion in profits. Earnings per share was $15.55.
| Revenue | 12.95B |
| Gross Profit | 7.10B |
| Operating Income | 4.89B |
| Pretax Income | 4.76B |
| Net Income | 3.98B |
| EBITDA | 5.10B |
| EBIT | 4.89B |
| Earnings Per Share (EPS) | $15.55 |
Balance Sheet
The company has $9.82 billion in cash and investments and $6.48 billion in debt, with a net cash position of $3.34 billion or $13.18 per share.
| Cash & Investments | 9.82B |
| Total Debt | 6.48B |
| Net Cash | 3.34B |
| Net Cash Per Share | $13.18 |
| Equity (Book Value) | 20.91B |
| Book Value Per Share | 82.47 |
| Working Capital | 6.69B |
Cash Flow
In the last 12 months, operating cash flow was $3.69 billion and capital expenditures -$492.30 million, giving a free cash flow of $3.20 billion.
| Operating Cash Flow | 3.69B |
| Capital Expenditures | -492.30M |
| Depreciation & Amortization | 206.10M |
| Net Borrowing | 4.49B |
| Free Cash Flow | 3.20B |
| FCF Per Share | $12.63 |
Margins
Gross margin is 54.81%, with operating and profit margins of 37.79% and 30.70%.
| Gross Margin | 54.81% |
| Operating Margin | 37.79% |
| Pretax Margin | 36.75% |
| Profit Margin | 30.70% |
| EBITDA Margin | 39.38% |
| EBIT Margin | 37.79% |
| FCF Margin | 24.73% |
Dividends & Yields
VRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.01% |
| Shareholder Yield | 1.01% |
| Earnings Yield | 2.84% |
| FCF Yield | 2.31% |
Analyst Forecast
The average price target for VRTX is $595.36, which is 8.84% higher than the current price. The consensus rating is "Buy".
| Price Target | $595.36 |
| Price Target Difference | 8.84% |
| Analyst Consensus | Buy |
| Analyst Count | 32 |
| Revenue Growth Forecast (3Y) | 11.13% |
| EPS Growth Forecast (3Y) | 8.87% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on August 24, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Aug 24, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
VRTX has an Altman Z-Score of 7.8 and a Piotroski F-Score of 4.
| Altman Z-Score | 7.8 |
| Piotroski F-Score | 4 |